Salvage chemotherapy in refractory germ cell tumors with etoposide (vp-16) plus ifosfamide plus high-dose cisplatin. A vihp regimen

Reporting results of cancer treatment

1981 • 7,916 citations

Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture.

1981 • 344 citations

High-Dose Cisplatin in Hypertonic Saline

1984 • 335 citations

VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.

1986 • 177 citations

Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimen

1983 • 146 citations

Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.

1985 • 144 citations

Ifosfamide in refractory male germ cell tumors.

1986 • 132 citations

Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors

1985 • 63 citations

Etoposide salvage therapy for refractory germ cell tumors: an update

1982 • 59 citations

Clinical overview of mesna

1983 • 58 citations

Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors

1982 • 27 citations

The treatment of stage III nonseminomatous testicular tumors. Roswell Park Memorial Institute results (1970–1979)

1983 • 8 citations